Mastering T cells to cure patients with solid tumors
Location: United States, Washington, Seattle
Investors 3
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | 8VC | 8vc.com |
| - | WRF Capita... | wrfseattle... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 05.03.2024 | Lyell Immunopharma Announces the Acceptance of Three Abstrac... | - | globenewsw... |
| 21.12.2022 | Tech Moves: Meta exec joins AI startup, Lyell Immunopharma h... | Claudiu Bulai. (Quantarium Photo) — Claudiu Bulai is now chief innovation officer at Bellevue, Wash.... | geekwire.c... |
| 10.06.2021 | Will legislation on competing with China spur the next big t... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 18.05.2021 | The 24 billion-dollar startups to watch that are revolutioni... | The Tempus lab. Tempus This story is available exclusively to Insider subscribers. Become an Insider... | businessin... |
| 05.04.2021 | Outpace Bio Raises $30 Million To Design Next Generation Cel... | Marc Lajoie, CEO of OutpaceOutpace Bio | forbes.com... |
| 25.02.2021 | Biotech and healthtech firm Foresite Capital raises $969M ne... | The firm, which now has over $4 billion in assets under management, invests across all stages The bi... | vator.tv/n... |